Company / Current Assets per Share
Edgewise Therapeutics, Inc. Current Assets per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$5.28
FY2025
5-year range
$5.13 / $7.56
FY2021-FY2025
Trend
+2.6%
vs FY2024
Sector context
#129 of 210
Health Care
What the data says
At $5.28, Edgewise Therapeutics, Inc.'s current assets per share ranks #129 of 210 in the Health Care sector. Improved from $5.13 to $5.28 over the past 2 years.
Based on SEC 10-K filings.
5.28 in FY2025 with a 5-year CAGR of -50.4%.
Improved from $5.13 to $5.28 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -7.5%
- 5-Year CAGR
- -50.4%
- 10-Year CAGR
- -
Sector benchmark
#129 of 210 in Health CareTop 61% of 210This company $5.28 Sector average $134.38
▼
-96.1% below sector average
Key checks
Key Insights
- In FY2025, current assets per share increased 2.6% year-over-year.
- Ranks #129 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2020.
- Lowest current assets per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 6.82 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.28 | +2.6% |
| FY2024 | $5.15 | +0.3% |
| FY2023 | $5.13 | -23.0% |
| FY2022 | $6.66 | -11.9% |
| FY2021 | $7.56 | -95.7% |
| FY2020 | $175.43 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026